⌘K
Loading ticker…
As of 2026-08-24, Rocket Pharmaceuticals, Inc. Common Stock (RCKT) has a 3-month relative strength percentile of 80 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.7%, relative volume 0.62×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
RCKT is held by 19 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $1M notional. Top 3 carry $3M.
Held by 38 ETFs · $45M across latest filings · largest weight 0.76% (BBC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $1M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $1M | — |
| VHTVanguard Health Care ETF | 0.00% | $744K | — |
| AVSC | 0.01% | $279K | — |
| GNOM | 0.32% | $177K | −0.04 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.01% |
| $170K |
| −0.01 pp |
| FSCC | 0.06% | $160K | new |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $158K | — |
| VTWG | 0.00% | $38K | — |
| IBBQ | 0.03% | $18K | −0.01 pp |
Showing 10 of 19 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RCKT Jan avg: -2.13% median: -2.50% win: 25% σ: 10.54% n: 4 2022-04-12 → 2026-07-31 | RCKT Feb avg: 5.58% median: -4.81% win: 50% σ: 26.40% n: 4 2022-04-12 → 2026-07-31 | RCKT Mar avg: -19.21% median: -19.68% win: 0% σ: 11.34% n: 4 2022-04-12 → 2026-07-31 | RCKT Apr avg: -5.81% median: -2.79% win: 40% σ: 16.61% n: 5 2022-04-12 → 2026-07-31 | RCKT May avg: -9.55% median: -0.93% win: 40% σ: 34.29% n: 5 2022-04-12 → 2026-07-31 | RCKT Jun avg: 4.21% median: 0.98% win: 60% σ: 9.13% n: 5 2022-04-12 → 2026-07-31 | RCKT Jul avg: 4.81% median: 5.38% win: 60% σ: 14.43% n: 5 2022-04-12 → 2026-07-31 | RCKT Aug avg: -5.40% median: -3.51% win: 50% σ: 14.67% n: 4 2022-04-12 → 2026-07-31 (current) | RCKT Sep avg: 7.97% median: 1.48% win: 50% σ: 15.49% n: 4 2022-04-12 → 2026-07-31 | RCKT Oct avg: 2.76% median: 2.90% win: 50% σ: 15.64% n: 4 2022-04-12 → 2026-07-31 | RCKT Nov avg: 1.80% median: -4.05% win: 50% σ: 19.09% n: 4 2022-04-12 → 2026-07-31 | RCKT Dec avg: 5.53% median: 3.14% win: 75% σ: 17.01% n: 4 2022-04-12 → 2026-07-31 |